JANE STREET GROUP, LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 177 filers reported holding CARA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$509,190
+661.0%
179,926
+1220.3%
0.00%
Q1 2023$66,914
-89.6%
13,628
-77.2%
0.00%
Q4 2022$643,251
+320.4%
59,893
+264.4%
0.00%
Q3 2022$153,000
-39.8%
16,435
-40.9%
0.00%
Q2 2022$254,000
-84.7%
27,818
-79.7%
0.00%
Q1 2022$1,662,000
-37.1%
136,714
-37.0%
0.00%
-100.0%
Q4 2021$2,644,000
-59.6%
217,090
-48.8%
0.00%
-50.0%
Q3 2021$6,546,000
+242.7%
423,680
+216.4%
0.00%
Q2 2021$1,910,000
-56.6%
133,918
-33.9%
0.00%
-100.0%
Q1 2021$4,400,000
+135.2%
202,688
+64.0%
0.00%
+100.0%
Q4 2020$1,871,000
+191.4%
123,627
+145.2%
0.00%
Q3 2020$642,000
-73.6%
50,429
-64.6%
0.00%
-100.0%
Q2 2020$2,435,000
+902.1%
142,400
+1050.1%
0.00%
Q1 2019$243,000
-56.2%
12,381
-46.6%
0.00%
-100.0%
Q3 2018$555,000
-25.5%
23,206
-40.3%
0.00%
-50.0%
Q2 2018$745,000
+55.2%
38,900
+0.3%
0.00%
+100.0%
Q1 2018$480,000
+172.7%
38,800
+201.0%
0.00%0.0%
Q3 2017$176,000
-88.3%
12,889
-86.9%
0.00%
-83.3%
Q2 2017$1,509,000
+7.9%
98,047
+28.8%
0.01%0.0%
Q1 2017$1,399,000
+320.1%
76,098
+112.6%
0.01%
+500.0%
Q4 2016$333,000
-34.4%
35,800
-41.2%
0.00%
-50.0%
Q3 2016$508,000
+595.9%
60,862
+417.5%
0.00%
Q1 2016$73,000
-58.8%
11,761
+11.7%
0.00%
-100.0%
Q4 2015$177,000
-23.0%
10,526
-14.7%
0.00%
-66.7%
Q1 2014$230,00012,3400.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,193,057$51,440,00039.10%
Chescapmanager LLC 1,299,701$20,938,0003.08%
Burrage Capital Management LLC 284,170$4,578,0003.07%
Cypress Capital Management LLC (WY) 184,085$2,966,0002.80%
DAFNA Capital Management LLC 328,533$5,293,0001.82%
Mesirow Financial Investment Management, Inc. 21,169$341,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 471,575$7,597,0001.14%
AdvisorShares Investments LLC 79,821$1,286,0000.80%
ETF MANAGERS GROUP, LLC 750,680$12,093,0000.42%
FARALLON CAPITAL MANAGEMENT LLC 2,300,000$37,053,0000.25%
View complete list of CARA THERAPEUTICS INC shareholders